Financial Metrics

DGX QUEST DIAGNOSTICS INC

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.71	—	USD/shares	10-Q	2017-04-21
Quarterly	2016-06-30	1.37	+93.0%	USD/shares	10-Q	2017-07-25
Quarterly	2016-09-30	1.34	-2.2%	USD/shares	10-Q	2017-10-19
Quarterly	2017-03-31	1.16	-13.4%	USD/shares	10-Q	2018-04-20
Quarterly	2017-06-30	1.37	+18.1%	USD/shares	10-Q	2018-07-25
Quarterly	2017-09-30	1.15	-16.1%	USD/shares	10-Q	2018-10-24
Quarterly	2018-03-31	1.27	+10.4%	USD/shares	10-Q	2019-04-24
Quarterly	2018-06-30	1.57	+23.6%	USD/shares	10-Q	2019-07-24
Quarterly	2018-09-30	1.53	-2.5%	USD/shares	10-Q	2019-10-23
Quarterly	2019-03-31	1.2	-21.6%	USD/shares	10-Q	2020-05-04
Quarterly	2019-06-30	1.66	+38.3%	USD/shares	10-Q	2020-07-24
Quarterly	2019-09-30	1.56	-6.0%	USD/shares	10-Q	2020-10-23
Quarterly	2020-03-31	0.73	-53.2%	USD/shares	10-Q	2021-04-23
Quarterly	2020-06-30	1.36	+86.3%	USD/shares	10-Q	2021-07-23
Quarterly	2020-09-30	4.14	+204.4%	USD/shares	10-Q	2021-10-22
Quarterly	2021-03-31	3.46	-16.4%	USD/shares	10-Q	2022-04-22
Quarterly	2021-06-30	4.96	+43.4%	USD/shares	10-Q	2022-07-22
Quarterly	2021-09-30	4.02	-19.0%	USD/shares	10-Q	2022-10-21
Quarterly	2022-03-31	2.92	-27.4%	USD/shares	10-Q	2023-04-28
Quarterly	2022-06-30	1.96	-32.9%	USD/shares	10-Q	2023-07-27
Quarterly	2022-09-30	2.17	+10.7%	USD/shares	10-Q	2023-10-25
Quarterly	2023-03-31	1.78	-18.0%	USD/shares	10-Q	2024-04-24
Quarterly	2023-06-30	2.05	+15.2%	USD/shares	10-Q	2024-07-24
Quarterly	2023-09-30	1.96	-4.4%	USD/shares	10-Q	2024-10-23
Quarterly	2024-03-31	1.72	-12.2%	USD/shares	10-Q	2025-04-23
Quarterly	2024-06-30	2.03	+18.0%	USD/shares	10-Q	2025-07-23
Quarterly	2024-09-30	1.99	-2.0%	USD/shares	10-Q	2025-10-21
Quarterly	2025-03-31	1.94	-2.5%	USD/shares	10-Q	2025-04-23
Quarterly	2025-06-30	2.47	+27.3%	USD/shares	10-Q	2025-07-23
Quarterly	2025-09-30	2.16	-12.6%	USD/shares	10-Q	2025-10-21
Annual	2016-12-31	4.51	—	USD/shares	10-K	2019-02-21
Annual	2017-12-31	5.5	+22.0%	USD/shares	10-K	2020-02-20
Annual	2018-12-31	5.29	-3.8%	USD/shares	10-K	2021-02-22
Annual	2019-12-31	6.28	+18.7%	USD/shares	10-K	2022-02-28
Annual	2020-12-31	10.47	+66.7%	USD/shares	10-K	2023-02-21
Annual	2021-12-31	15.55	+48.5%	USD/shares	10-K	2024-02-22
Annual	2022-12-31	7.97	-48.7%	USD/shares	10-K	2025-02-20
Annual	2023-12-31	7.49	-6.0%	USD/shares	10-K	2026-02-26
Annual	2024-12-31	7.69	+2.7%	USD/shares	10-K	2026-02-26
Annual	2025-12-31	8.75	+13.8%	USD/shares	10-K	2026-02-26

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	3898000000.0	—	USD	10-Q	2016-04-27
Quarterly	2016-06-30	3842000000.0	-1.4%	USD	10-Q	2016-07-25
Quarterly	2016-09-30	3822000000.0	-0.5%	USD	10-Q	2016-10-21
Quarterly	2018-12-31	3893000000.0	+1.9%	USD	10-Q	2019-10-23
Quarterly	2019-03-31	4239000000.0	+8.9%	USD	10-Q	2019-04-24
Quarterly	2019-06-30	3976000000.0	-6.2%	USD	10-Q	2019-07-24
Quarterly	2019-09-30	3993000000.0	+0.4%	USD	10-Q	2019-10-23
Quarterly	2019-12-31	4770000000.0	+19.5%	USD	10-Q	2020-10-23
Quarterly	2020-03-31	4036000000.0	-15.4%	USD	10-Q	2020-05-04
Quarterly	2020-06-30	4575000000.0	+13.4%	USD	10-Q	2020-07-24
Quarterly	2020-09-30	4573000000.0	-0.0%	USD	10-Q	2020-10-23
Quarterly	2023-12-31	4713000000.0	+3.1%	USD	10-Q	2024-10-23
Quarterly	2024-09-30	6251000000.0	+32.6%	USD	10-Q	2024-10-23
Annual	2016-12-31	3734000000.0	—	USD	10-K	2018-02-23
Annual	2017-12-31	3784000000.0	+1.3%	USD	10-K	2019-02-21
Annual	2018-12-31	3893000000.0	+2.9%	USD	10-K	2020-02-20
Annual	2019-12-31	4770000000.0	+22.5%	USD	10-K	2021-02-22
Annual	2020-12-31	4015000000.0	-15.8%	USD	10-K	2022-02-28
Annual	2021-12-31	4012000000.0	-0.1%	USD	10-K	2023-02-21
Annual	2022-12-31	3980000000.0	-0.8%	USD	10-K	2024-02-22
Annual	2023-12-31	4713000000.0	+18.4%	USD	10-K	2025-02-20
Annual	2024-12-31	6217000000.0	+31.9%	USD	10-K	2026-02-26
Annual	2025-12-31	5671000000.0	-8.8%	USD	10-K	2026-02-26

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	47000000.0	—	USD	10-Q	2017-04-21
Quarterly	2016-06-30	104000000.0	+121.3%	USD	10-Q	2017-07-25
Quarterly	2016-09-30	165000000.0	+58.7%	USD	10-Q	2017-10-19
Quarterly	2017-03-31	42000000.0	-74.5%	USD	10-Q	2018-04-20
Quarterly	2017-06-30	107000000.0	+154.8%	USD	10-Q	2018-07-25
Quarterly	2017-09-30	170000000.0	+58.9%	USD	10-Q	2018-10-24
Quarterly	2018-03-31	73000000.0	-57.1%	USD	10-Q	2019-04-24
Quarterly	2018-06-30	151000000.0	+106.8%	USD	10-Q	2019-07-24
Quarterly	2018-09-30	232000000.0	+53.6%	USD	10-Q	2019-10-23
Quarterly	2019-03-31	47000000.0	-79.7%	USD	10-Q	2020-05-04
Quarterly	2019-06-30	132000000.0	+180.9%	USD	10-Q	2020-07-24
Quarterly	2019-09-30	228000000.0	+72.7%	USD	10-Q	2020-10-23
Quarterly	2020-03-31	83000000.0	-63.6%	USD	10-Q	2021-04-23
Quarterly	2020-06-30	165000000.0	+98.8%	USD	10-Q	2021-07-23
Quarterly	2020-09-30	256000000.0	+55.2%	USD	10-Q	2021-10-22
Quarterly	2021-03-31	86000000.0	-66.4%	USD	10-Q	2022-04-22
Quarterly	2021-06-30	170000000.0	+97.7%	USD	10-Q	2022-07-22
Quarterly	2021-09-30	259000000.0	+52.4%	USD	10-Q	2022-10-21
Quarterly	2022-03-31	63000000.0	-75.7%	USD	10-Q	2023-04-28
Quarterly	2022-06-30	139000000.0	+120.6%	USD	10-Q	2023-07-27
Quarterly	2022-09-30	257000000.0	+84.9%	USD	10-Q	2023-10-25
Quarterly	2023-03-31	127000000.0	-50.6%	USD	10-Q	2024-04-24
Quarterly	2023-06-30	231000000.0	+81.9%	USD	10-Q	2024-07-24
Quarterly	2023-09-30	336000000.0	+45.5%	USD	10-Q	2024-10-23
Quarterly	2024-03-31	104000000.0	-69.0%	USD	10-Q	2025-04-23
Quarterly	2024-06-30	196000000.0	+88.5%	USD	10-Q	2025-07-23
Quarterly	2024-09-30	302000000.0	+54.1%	USD	10-Q	2025-10-21
Quarterly	2025-03-31	117000000.0	-61.3%	USD	10-Q	2025-04-23
Quarterly	2025-06-30	225000000.0	+92.3%	USD	10-Q	2025-07-23
Quarterly	2025-09-30	369000000.0	+64.0%	USD	10-Q	2025-10-21
Annual	2016-12-31	293000000.0	—	USD	10-K	2019-02-21
Annual	2017-12-31	252000000.0	-14.0%	USD	10-K	2020-02-20
Annual	2018-12-31	383000000.0	+52.0%	USD	10-K	2021-02-22
Annual	2019-12-31	400000000.0	+4.4%	USD	10-K	2022-02-28
Annual	2020-12-31	418000000.0	+4.5%	USD	10-K	2023-02-21
Annual	2021-12-31	403000000.0	-3.6%	USD	10-K	2024-02-22
Annual	2022-12-31	404000000.0	+0.2%	USD	10-K	2025-02-20
Annual	2023-12-31	408000000.0	+1.0%	USD	10-K	2026-02-26
Annual	2024-12-31	425000000.0	+4.2%	USD	10-K	2026-02-26
Annual	2025-12-31	527000000.0	+24.0%	USD	10-K	2026-02-26

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	144000000.0	—	shares	10-Q	2017-04-21
Quarterly	2016-06-30	142000000.0	-1.4%	shares	10-Q	2017-07-25
Quarterly	2016-09-30	142000000.0	+0.0%	shares	10-Q	2017-10-19
Quarterly	2017-03-31	141000000.0	-0.7%	shares	10-Q	2018-04-20
Quarterly	2017-06-30	140000000.0	-0.7%	shares	10-Q	2018-07-25
Quarterly	2017-09-30	140000000.0	+0.0%	shares	10-Q	2018-10-24
Quarterly	2018-03-31	139000000.0	-0.7%	shares	10-Q	2019-04-24
Quarterly	2018-06-30	139000000.0	+0.0%	shares	10-Q	2019-07-24
Quarterly	2018-09-30	139000000.0	+0.0%	shares	10-Q	2019-10-23
Quarterly	2019-03-31	136000000.0	-2.2%	shares	10-Q	2020-05-04
Quarterly	2019-06-30	136000000.0	+0.0%	shares	10-Q	2020-07-24
Quarterly	2019-09-30	137000000.0	+0.7%	shares	10-Q	2020-10-23
Quarterly	2020-03-31	135000000.0	-1.5%	shares	10-Q	2021-04-23
Quarterly	2020-06-30	136000000.0	+0.7%	shares	10-Q	2021-07-23
Quarterly	2020-09-30	137000000.0	+0.7%	shares	10-Q	2021-10-22
Quarterly	2021-03-31	135000000.0	-1.5%	shares	10-Q	2022-04-22
Quarterly	2021-06-30	127000000.0	-5.9%	shares	10-Q	2022-07-22
Quarterly	2021-09-30	125000000.0	-1.6%	shares	10-Q	2022-10-21
Quarterly	2022-03-31	121000000.0	-3.2%	shares	10-Q	2023-04-28
Quarterly	2022-06-30	119000000.0	-1.7%	shares	10-Q	2023-07-27
Quarterly	2022-09-30	118000000.0	-0.8%	shares	10-Q	2023-10-25
Quarterly	2023-03-31	113000000.0	-4.2%	shares	10-Q	2024-04-24
Quarterly	2023-06-30	114000000.0	+0.9%	shares	10-Q	2024-07-24
Quarterly	2023-09-30	114000000.0	+0.0%	shares	10-Q	2024-10-23
Quarterly	2024-03-31	112000000.0	-1.8%	shares	10-Q	2025-04-23
Quarterly	2024-06-30	112000000.0	+0.0%	shares	10-Q	2025-07-23
Quarterly	2024-09-30	113000000.0	+0.9%	shares	10-Q	2025-10-21
Quarterly	2025-03-31	113000000.0	+0.0%	shares	10-Q	2025-04-23
Quarterly	2025-06-30	113000000.0	+0.0%	shares	10-Q	2025-07-23
Quarterly	2025-09-30	113000000.0	+0.0%	shares	10-Q	2025-10-21
Annual	2016-12-31	142000000.0	—	shares	10-K	2019-02-21
Annual	2017-12-31	140000000.0	-1.4%	shares	10-K	2020-02-20
Annual	2018-12-31	139000000.0	-0.7%	shares	10-K	2021-02-22
Annual	2019-12-31	136000000.0	-2.2%	shares	10-K	2022-02-28
Annual	2020-12-31	136000000.0	+0.0%	shares	10-K	2023-02-21
Annual	2021-12-31	128000000.0	-5.9%	shares	10-K	2024-02-22
Annual	2022-12-31	118000000.0	-7.8%	shares	10-K	2025-02-20
Annual	2023-12-31	113000000.0	-4.2%	shares	10-K	2026-02-26
Annual	2024-12-31	113000000.0	+0.0%	shares	10-K	2026-02-26
Annual	2025-12-31	113000000.0	+0.0%	shares	10-K	2026-02-26

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

5,671,000,000

Total Liabilities (latest annual)

N/A

Current Liabilities (latest annual)

2,278,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0247	—	ratio	10-Q	2017-04-21
Quarterly	2016-06-30	0.0457	+85.6%	ratio	10-Q	2017-07-25
Quarterly	2016-09-30	0.0437	-4.5%	ratio	10-Q	2017-10-19
Quarterly	2017-03-31	0.0375	-14.1%	ratio	10-Q	2018-04-20
Quarterly	2017-06-30	0.0437	+16.5%	ratio	10-Q	2018-07-25
Quarterly	2017-09-30	0.0362	-17.1%	ratio	10-Q	2018-10-24
Quarterly	2018-03-31	0.0373	+2.9%	ratio	10-Q	2019-04-24
Quarterly	2018-06-30	0.0443	+18.7%	ratio	10-Q	2019-07-24
Quarterly	2018-09-30	0.0423	-4.4%	ratio	10-Q	2019-10-23
Quarterly	2019-03-31	0.0330	-22.1%	ratio	10-Q	2020-05-04
Quarterly	2019-06-30	0.0434	+31.7%	ratio	10-Q	2020-07-24
Quarterly	2019-09-30	0.0400	-7.9%	ratio	10-Q	2020-10-23
Quarterly	2020-03-31	0.0186	-53.5%	ratio	10-Q	2021-04-23
Quarterly	2020-06-30	0.0328	+76.6%	ratio	10-Q	2021-07-23
Quarterly	2020-09-30	0.0917	+179.4%	ratio	10-Q	2021-10-22
Quarterly	2021-03-31	0.0722	-21.3%	ratio	10-Q	2022-04-22
Quarterly	2021-06-30	0.1094	+51.6%	ratio	10-Q	2022-07-22
Quarterly	2021-09-30	0.0819	-25.1%	ratio	10-Q	2022-10-21
Quarterly	2022-03-31	0.0581	-29.0%	ratio	10-Q	2023-04-28
Quarterly	2022-06-30	0.0388	-33.3%	ratio	10-Q	2023-07-27
Quarterly	2022-09-30	0.0440	+13.5%	ratio	10-Q	2023-10-25
Quarterly	2023-03-31	0.0356	-19.0%	ratio	10-Q	2024-04-24
Quarterly	2023-06-30	0.0396	+11.1%	ratio	10-Q	2024-07-24
Quarterly	2023-09-30	0.0367	-7.4%	ratio	10-Q	2024-10-23
Quarterly	2024-03-31	0.0322	-12.3%	ratio	10-Q	2025-04-23
Quarterly	2024-06-30	0.0361	+12.1%	ratio	10-Q	2025-07-23
Quarterly	2024-09-30	0.0346	-3.9%	ratio	10-Q	2025-10-21
Quarterly	2025-03-31	0.0338	-2.6%	ratio	10-Q	2025-04-23
Quarterly	2025-06-30	0.0407	+20.7%	ratio	10-Q	2025-07-23
Quarterly	2025-09-30	0.0355	-12.9%	ratio	10-Q	2025-10-21
Annual	2016-12-31	0.1494	—	ratio	10-K	2019-02-21
Annual	2017-12-31	0.1663	+11.3%	ratio	10-K	2020-02-20
Annual	2018-12-31	0.1496	-10.0%	ratio	10-K	2021-02-22
Annual	2019-12-31	0.1593	+6.5%	ratio	10-K	2022-02-28
Annual	2020-12-31	0.2201	+38.2%	ratio	10-K	2023-02-21
Annual	2021-12-31	0.3208	+45.7%	ratio	10-K	2024-02-22
Annual	2022-12-31	0.1712	-46.7%	ratio	10-K	2025-02-20
Annual	2023-12-31	0.1432	-16.4%	ratio	10-K	2026-02-26
Annual	2024-12-31	0.1352	-5.6%	ratio	10-K	2026-02-26
Annual	2025-12-31	0.1452	+7.4%	ratio	10-K	2026-02-26

8-K Material Event Details

53 filings · 114 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

592 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-04-01	WENTWORTH TIMOTHY C	Dir	Equity grant / award A · derivative	Phantom Stock Units	198	$0.00	$0	198
2026-03-09	WENTWORTH TIMOTHY C	Dir	Equity grant / award A	Common Stock	215	$0.00	$0	215
2026-03-04	SAMAD SAM	Executive Vice President & CFO	Other disposed transaction F	Common Stock	7,720	$204.86	$1,581,519	33,268
2026-03-04	SAMAD SAM	Executive Vice President & CFO	Equity grant / award A	Common Stock	13,947	$204.86	$2,857,182	40,988
2026-03-03	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	632	$207.73	$131,285	67,122
2026-03-02	Doherty Catherine T.	EVP, Regional Businesses	Other disposed transaction F	Common Stock	648	$204.86	$132,749	67,754
2026-02-19	Plewman Patrick	SVP for Diagnostic Services	Open-market sell S	Common Stock	958	$204.83	$196,227	15,838
2026-02-18	Plewman Patrick	SVP for Diagnostic Services	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	9,009	$0.00	$0	9,009
2026-02-18	Plewman Patrick	SVP for Diagnostic Services	Other disposed transaction F	Common Stock	293	$206.99	$60,648	16,796
2026-02-18	Plewman Patrick	SVP for Diagnostic Services	Other disposed transaction F	Common Stock	244	$210.01	$51,242	17,089
2026-02-18	Plewman Patrick	SVP for Diagnostic Services	Equity grant / award A	Common Stock	1,952	$0.00	$0	17,333
2026-02-13	Doherty Catherine T.	EVP, Regional Businesses	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	26,165	$112.17	$2,934,928	0
2026-02-13	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	351	$209.10	$73,395	68,068
2026-02-13	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	1,619	$208.21	$337,093	68,419
2026-02-13	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	3,500	$207.08	$724,788	70,038
2026-02-13	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	10,122	$206.37	$2,088,883	73,538
2026-02-13	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	10,573	$205.21	$2,169,656	83,660
2026-02-13	Doherty Catherine T.	EVP, Regional Businesses	Exercise / conversion M	Common Stock	26,165	$112.17	$2,934,928	94,233
2026-01-28	Lassiter Wright III	Dir	Equity grant / award L	Common Stock	7	$183.51	$1,285	9,057
2025-11-25	Davis J. E.	CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	55,093	$95.80	$5,277,634	0
2025-11-25	Davis J. E.	CEO and President	Open-market sell S	Common Stock	4,747	$192.97	$916,037	120,480
2025-11-25	Davis J. E.	CEO and President	Open-market sell S	Common Stock	41,004	$192.27	$7,883,901	125,227
2025-11-25	Davis J. E.	CEO and President	Open-market sell S	Common Stock	9,342	$191.59	$1,789,823	166,231
2025-11-25	Davis J. E.	CEO and President	Exercise / conversion M	Common Stock	55,093	$95.80	$5,277,634	175,573
2025-11-18	DELANEY MARK E	SVP & Chief Commercial Officer	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	100	$143.33	$14,333	7,484
2025-11-18	DELANEY MARK E	SVP & Chief Commercial Officer	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	7,846	$144.47	$1,133,512	0
2025-11-18	DELANEY MARK E	SVP & Chief Commercial Officer	Open-market sell S	Common Stock	7,946	$187.35	$1,488,683	7,530
2025-11-18	DELANEY MARK E	SVP & Chief Commercial Officer	Exercise / conversion M	Common Stock	100	$143.33	$14,333	15,476
2025-11-18	DELANEY MARK E	SVP & Chief Commercial Officer	Exercise / conversion M	Common Stock	7,846	$144.47	$1,133,512	15,376
2025-11-05	Davis J. E.	CEO and President	Other disposed transaction F	Common Stock	7,143	$175.57	$1,254,097	120,480
2025-10-23	PFEIFFER GARY M	Dir	Other disposed transaction I · derivative	Phantom Stock	4,413	$190.58	$841,084	0
2025-10-22	PFEIFFER GARY M	Dir	Open-market sell S	Common Stock	1,482	$182.40	$270,317	29,431
2025-10-21	SAMAD SAM	Executive Vice President & CFO	Equity grant / award A	Common Stock	68	$189.08	$12,858	25,741
2025-10-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	233	$0.00	$0	17,036
2025-09-26	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	227	$103.57	$23,510	0
2025-09-26	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	144	$188.66	$27,167	38,117
2025-09-26	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	83	$187.22	$15,539	38,261
2025-09-26	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	227	$103.57	$23,510	38,344
2025-09-24	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	175	$103.57	$18,125	227
2025-09-24	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	175	$187.02	$32,729	38,117
2025-09-24	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	175	$103.57	$18,125	38,292
2025-09-23	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	28,288	$103.57	$2,929,788	402
2025-09-23	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	28,288	$187.12	$5,293,313	38,117
2025-09-23	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	28,288	$103.57	$2,929,788	66,405
2025-08-21	Plewman Patrick	SVP for Diagnostic Services	Open-market sell S	Common Stock	1,975	$185.00	$365,375	15,269
2025-08-19	Plewman Patrick	SVP for Diagnostic Services	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	4,532	$112.17	$508,354	0
2025-08-19	Plewman Patrick	SVP for Diagnostic Services	Open-market sell S	Common Stock	4,532	$183.00	$829,356	17,244
2025-08-19	Plewman Patrick	SVP for Diagnostic Services	Exercise / conversion M	Common Stock	4,532	$112.17	$508,354	21,776
2025-08-15	Plewman Patrick	SVP for Diagnostic Services	Open-market sell S	Common Stock	1,975	$180.00	$355,500	17,244
2025-08-13	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Other disposed transaction F	Common Stock	123	$175.91	$21,637	8,338
2025-08-06	Plewman Patrick	SVP for Diagnostic Services	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	3,560	$86.63	$308,403	0
2025-08-06	Plewman Patrick	SVP for Diagnostic Services	Open-market sell S	Common Stock	1,975	$175.00	$345,625	19,219
2025-08-06	Plewman Patrick	SVP for Diagnostic Services	Open-market sell S	Common Stock	3,560	$175.00	$623,000	21,185
2025-08-06	Plewman Patrick	SVP for Diagnostic Services	Exercise / conversion M	Common Stock	3,560	$86.63	$308,403	24,745
2025-07-31	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Open-market sell S	Common Stock	2,210	$170.00	$375,700	8,450
2025-07-30	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	5,224	$112.17	$585,976	0
2025-07-30	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	3,045	$86.63	$263,788	0
2025-07-30	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Open-market sell S	Common Stock	5,224	$167.40	$874,498	10,660
2025-07-30	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Exercise / conversion M	Common Stock	5,224	$112.17	$585,976	15,884
2025-07-30	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Open-market sell S	Common Stock	3,045	$167.40	$509,733	10,660
2025-07-30	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Exercise / conversion M	Common Stock	3,045	$86.63	$263,788	13,705
2025-07-21	SAMAD SAM	Executive Vice President & CFO	Equity grant / award L	Common Stock	72	$167.50	$12,060	25,673
2025-07-16	SAMAD SAM	Executive Vice President & CFO	Other disposed transaction F	Common Stock	850	$169.01	$143,658	25,601
2025-07-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	236	$0.00	$0	16,725
2025-05-15	CARTER ROBERT B	Dir	Equity grant / award A	Common Stock	1,203	$0.00	$0	2,685
2025-05-13	DELANEY MARK E	SVP & Chief Commercial Officer	Open-market sell S	Common Stock	874	$175.31	$153,221	7,498
2025-05-12	DELANEY MARK E	SVP & Chief Commercial Officer	Open-market sell S	Common Stock	874	$175.72	$153,579	8,372
2025-04-21	SAMAD SAM	Executive Vice President & CFO	Equity grant / award L	Common Stock	74	$164.42	$12,167	26,451
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	453	$169.63	$76,844	127,623
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	902	$168.79	$152,249	128,076
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	1,493	$167.88	$250,643	128,978
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	267	$169.60	$45,282	130,471
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	584	$168.70	$98,520	130,738
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	750	$167.86	$125,897	131,322
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	2,493	$169.57	$422,736	132,072
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	5,900	$168.66	$995,121	134,565
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	6,950	$167.86	$1,166,627	140,465
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	2,764	$169.56	$468,662	147,415
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	4,905	$168.72	$827,564	150,179
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	7,249	$167.86	$1,216,845	155,084
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	704	$169.63	$119,416	162,333
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	1,411	$168.76	$238,114	163,037
2025-04-02	Davis J. E.	CEO and President	Open-market sell S	Common Stock	2,366	$168.03	$397,553	164,448
2025-04-01	Lassiter Wright III	Dir	Equity grant / award A · derivative	Phantom Stock Units	169	$0.00	$0	360
2025-03-26	Plewman Patrick	SVP for Diagnostic Services	Other disposed transaction F	Common Stock	162	$166.71	$27,007	20,988
2025-03-17	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	4,643	$170.00	$789,310	38,117
2025-03-05	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	5,370	$174.13	$935,078	68,068
2025-03-04	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	867	$173.74	$150,633	34,365
2025-03-04	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Equity grant / award A	Common Stock	1,711	$173.74	$297,269	35,232
2025-03-04	DELANEY MARK E	SVP & Chief Commercial Officer	Other disposed transaction F	Common Stock	1,823	$173.74	$316,728	9,477
2025-03-04	DELANEY MARK E	SVP & Chief Commercial Officer	Equity grant / award A	Common Stock	5,317	$173.74	$923,776	11,300
2025-03-03	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	1,692	$173.74	$293,968	33,521
2025-02-26	SAMAD SAM	Executive Vice President & CFO	Other disposed transaction F	Common Stock	869	$171.75	$149,251	20,177
2025-02-19	SAMAD SAM	Executive Vice President & CFO	Other disposed transaction F	Common Stock	1,031	$169.71	$174,971	21,046
2025-02-12	Davis J. E.	CEO and President	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	69,633	$0.00	$0	69,633
2025-02-12	Davis J. E.	CEO and President	Equity grant / award A	Common Stock	18,149	$0.00	$0	144,117
2025-02-05	Gregg Vicky B	Dir	Open-market sell S	Common Stock	1,250	$164.57	$205,710	16,867
2025-01-29	Gregg Vicky B	Dir	Equity grant / award L	Common Stock	72	$158.04	$11,379	18,117
2025-01-02	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	281	$0.00	$0	16,081
2024-11-29	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	35,146	$86.63	$3,044,698	0
2024-11-29	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	32,137	$163.15	$5,243,065	38,478
2024-11-29	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	3,009	$162.26	$488,237	70,615
2024-11-29	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	35,146	$86.63	$3,044,698	73,624
2024-11-27	Doherty Catherine T.	EVP, Regional Businesses	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	33,103	$103.57	$3,428,478	0
2024-11-27	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	28,300	$163.13	$4,616,709	68,412
2024-11-27	Doherty Catherine T.	EVP, Regional Businesses	Open-market sell S	Common Stock	4,803	$162.14	$778,775	96,712
2024-11-27	Doherty Catherine T.	EVP, Regional Businesses	Exercise / conversion M	Common Stock	33,103	$103.57	$3,428,478	101,515
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	10,120	$66.51	$673,081	0
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	8,635	$71.17	$614,553	0
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Open-market sell S	Common Stock	5,189	$154.74	$802,958	34,941
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Open-market sell S	Common Stock	2,331	$154.03	$359,046	40,130
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Open-market sell S	Common Stock	2,600	$152.71	$397,050	42,461
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Open-market sell S	Common Stock	4,135	$154.74	$639,833	45,061
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Open-market sell S	Common Stock	2,400	$153.98	$369,559	49,196
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Open-market sell S	Common Stock	2,100	$152.70	$320,676	51,596
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Exercise / conversion M	Common Stock	10,120	$66.51	$673,081	53,696
2024-11-06	DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Exercise / conversion M	Common Stock	8,635	$71.17	$614,553	43,576
2024-10-28	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Open-market sell S	Common Stock	1,775	$156.92	$278,525	9,734
2024-10-21	Gregg Vicky B	Dir	Equity grant / award L	Common Stock	76	$149.37	$11,352	18,045
2024-10-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	275	$0.00	$0	15,721
2024-09-24	GARDNER MARK A	SVP of Molecular Gen & Oncol	Other disposed transaction F	Common Stock	120	$155.70	$18,684	4,673
2024-08-29	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	32,551	$95.80	$3,118,223	0
2024-08-29	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	32,551	$154.97	$5,044,516	38,478
2024-08-29	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	32,551	$95.80	$3,118,223	71,029
2024-08-28	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Open-market sell S	Common Stock	1,990	$153.26	$304,990	11,459
2024-08-14	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Other disposed transaction F	Common Stock	74	$149.46	$11,060	13,449
2024-07-24	DELANEY MARK E	SVP & Chief Commercial Officer	Open-market sell S	Common Stock	420	$143.08	$60,094	5,019
2024-07-22	SAMAD SAM	Executive Vice President & CFO	Equity grant / award L	Common Stock	21	$146.97	$3,086	17,467
2024-07-22	DELANEY MARK E	SVP & Chief Commercial Officer	Equity grant / award L	Common Stock	6	$146.98	$882	5,439
2024-07-16	SAMAD SAM	Executive Vice President & CFO	Other disposed transaction F	Common Stock	3,910	$142.65	$557,762	17,446
2024-07-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	308	$0.00	$0	15,367
2024-05-16	CARTER ROBERT B	Dir	Equity grant / award A	Common Stock	1,482	$0.00	$0	1,482
2024-04-29	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Open-market sell S	Common Stock	1,760	$140.00	$246,400	13,435
2024-04-22	Gregg Vicky B	Dir	Equity grant / award A	Common Stock	81	$126.24	$10,226	16,410
2024-04-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	311	$0.00	$0	14,973
2024-03-26	DELANEY MARK E	SVP & Chief Commercial Officer	Other disposed transaction F	Common Stock	170	$128.11	$21,779	5,433
2024-02-28	Plewman Patrick	SVP for Diagnostic Services	Other disposed transaction F	Common Stock	105	$126.36	$13,268	16,082
2024-02-28	Plewman Patrick	SVP for Diagnostic Services	Other disposed transaction F	Common Stock	228	$126.36	$28,810	16,187
2024-02-23	Davis J. E.	CEO and President	Other disposed transaction F	Common Stock	6,525	$125.02	$815,756	130,988
2024-02-23	Davis J. E.	CEO and President	Equity grant / award A	Common Stock	13,390	$125.02	$1,674,018	137,513
2024-02-21	Plewman Patrick	SVP for Diagnostic Services	Other disposed transaction F	Common Stock	139	$125.02	$17,378	14,896
2024-02-14	Davis J. E.	CEO and President	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	92,779	$0.00	$0	92,779
2024-02-14	Davis J. E.	CEO and President	Equity grant / award A	Common Stock	22,251	$0.00	$0	124,885
2024-01-31	Gregg Vicky B	Dir	Equity grant / award A	Common Stock	88	$129.33	$11,381	18,829
2024-01-02	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	294	$0.00	$0	14,582
2023-10-23	Gregg Vicky B	Dir	Equity grant / award A	Common Stock	92	$122.86	$11,303	18,741
2023-10-02	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	344	$0.00	$0	14,206
2023-09-25	GARDNER MARK A	SVP of Molecular Gen & Oncol	Other disposed transaction F	Common Stock	116	$126.22	$14,642	2,805
2023-08-15	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Other disposed transaction F	Common Stock	74	$135.23	$10,007	11,294
2023-07-25	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Equity grant / award A	Common Stock	25	$144.59	$3,615	11,355
2023-07-14	SAMAD SAM	Executive Vice President & CFO	Other disposed transaction F	Common Stock	3,909	$140.18	$547,964	16,475
2023-07-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	297	$0.00	$0	13,793
2023-05-17	Diaz Luis	Dir	Equity grant / award A	Common Stock	1,369	$0.00	$0	1,369
2023-04-24	Plewman Patrick	SVP for Diagnostic Services	Equity grant / award L	Common Stock	44	$143.08	$6,296	12,319
2023-04-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	291	$0.00	$0	13,431
2023-03-24	Plewman Patrick	SVP for Diagnostic Services	Other disposed transaction F	Common Stock	99	$134.25	$13,291	12,258
2023-03-07	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	4,754	$140.55	$668,175	38,527
2023-03-06	PREVOZNIK MICHAEL E	SVP & General Counsel	Other disposed transaction F	Common Stock	3,841	$147.86	$567,930	43,281
2023-03-06	PREVOZNIK MICHAEL E	SVP & General Counsel	Equity grant / award A	Common Stock	8,595	$147.86	$1,270,857	47,122
2023-03-03	Doherty Catherine T.	SVP, Regional Businesses	Open-market sell S	Common Stock	717	$140.63	$100,832	67,810
2023-03-01	RUSCKOWSKI STEPHEN H	Dir	Other disposed transaction F	Common Stock	3,496	$140.69	$491,852	345,570
2023-02-23	Davis J. E.	CEO and President	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	68,956	$0.00	$0	68,956
2023-02-23	Davis J. E.	CEO and President	Equity grant / award A	Common Stock	17,443	$0.00	$0	96,758
2023-02-23	Davis J. E.	CEO and President	Other disposed transaction F	Common Stock	1,473	$147.86	$217,798	79,315
2023-02-01	Gregg Vicky B	Dir	Equity grant / award L	Common Stock	64	$146.75	$9,392	17,130
2023-01-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	267	$0.00	$0	13,082
2022-12-01	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	1,053	$53.12	$55,941	0
2022-12-01	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	972	$62.01	$60,274	0
2022-12-01	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	2,025	$152.50	$308,812	24,149
2022-12-01	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	1,053	$53.12	$55,941	26,174
2022-12-01	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	972	$62.01	$60,274	25,121
2022-11-28	Doherty Catherine T.	SVP, Regional Businesses	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	40,765	$86.63	$3,531,472	0
2022-11-28	Doherty Catherine T.	SVP, Regional Businesses	Open-market sell S	Common Stock	23,407	$149.37	$3,496,390	67,733
2022-11-28	Doherty Catherine T.	SVP, Regional Businesses	Open-market sell S	Common Stock	17,358	$148.92	$2,584,872	91,140
2022-11-28	Doherty Catherine T.	SVP, Regional Businesses	Exercise / conversion M	Common Stock	40,765	$86.63	$3,531,472	108,498
2022-11-01	Davis J. E.	CEO and President	Equity grant / award A	Common Stock	13,980	$0.00	$0	80,788
2022-10-26	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	6,371	$56.12	$357,541	0
2022-10-26	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	9,126	$52.16	$476,058	0
2022-10-26	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Open-market sell S	Common Stock	15,497	$145.00	$2,247,065	32,013
2022-10-26	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M	Common Stock	6,371	$56.12	$357,541	47,503
2022-10-26	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M	Common Stock	9,126	$52.16	$476,058	41,132
2022-10-19	Gregg Vicky B	Dir	Equity grant / award L	Common Stock	74	$127.67	$9,447	17,066
2022-10-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	333	$0.00	$0	12,748
2022-10-03	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	2,000	$61.23	$122,450	260
2022-10-03	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	2,000	$123.39	$246,780	23,933
2022-10-03	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	2,000	$61.23	$122,450	25,933
2022-09-01	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	2,000	$61.23	$122,450	2,260
2022-09-01	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	2,000	$125.02	$250,040	23,933
2022-09-01	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	2,000	$61.23	$122,450	25,933
2022-08-01	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	1,851	$61.23	$113,327	4,260
2022-08-01	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	149	$56.25	$8,381	0
2022-08-01	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	2,000	$136.04	$272,080	23,933
2022-08-01	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	1,851	$61.23	$113,327	25,933
2022-08-01	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	149	$56.25	$8,381	24,082
2022-07-20	Gregg Vicky B	Dir	Equity grant / award L	Common Stock	70	$134.47	$9,413	16,992
2022-07-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	308	$134.74	$41,498	12,355
2022-07-01	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	990	$58.69	$58,098	0
2022-07-01	RING TIMOTHY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	1,010	$56.25	$56,812	149
2022-07-01	RING TIMOTHY M	Dir	Open-market sell S	Common Stock	2,000	$133.47	$266,940	23,933
2022-07-01	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	990	$58.69	$58,098	25,933
2022-07-01	RING TIMOTHY M	Dir	Exercise / conversion M	Common Stock	1,010	$56.25	$56,812	24,943
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	14,854	$86.63	$1,286,802	0
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	10,037	$103.57	$1,039,532	0
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	900	$142.13	$127,921	334,833
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	4,131	$141.35	$583,909	335,733
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	9,823	$140.58	$1,380,927	339,864
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	14,854	$86.63	$1,286,802	349,687
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	651	$142.15	$92,540	334,833
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	2,565	$141.36	$362,591	335,484
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	6,821	$140.60	$959,046	338,049
2022-05-25	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	10,037	$103.57	$1,039,532	344,870
2022-05-24	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	156,282	$86.63	$13,538,710	14,854
2022-05-24	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	126,126	$103.57	$13,062,870	10,037
2022-05-24	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	156,282	$140.12	$21,898,546	334,833
2022-05-24	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	156,282	$86.63	$13,538,710	491,115
2022-05-24	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	126,126	$140.12	$17,672,775	334,833
2022-05-24	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	126,126	$103.57	$13,062,870	460,959
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	42,568	$86.63	$3,687,666	171,136
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	34,898	$103.57	$3,614,386	136,163
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	300	$142.24	$42,672	334,833
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	1,000	$141.51	$141,509	335,133
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	41,268	$140.12	$5,782,431	336,133
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	42,568	$86.63	$3,687,666	377,401
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	200	$142.25	$28,451	334,833
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	800	$141.54	$113,234	335,033
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	33,898	$140.12	$4,749,923	335,833
2022-05-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	34,898	$103.57	$3,614,386	369,731
2022-05-18	Gregg Vicky B	Dir	Equity grant / award A	Common Stock	1,292	$0.00	$0	16,922
2022-05-18	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	8	$136.98	$1,096	32,006
2022-05-17	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	50,604	$66.51	$3,365,672	0
2022-05-17	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	50,604	$139.97	$7,082,991	39,224
2022-05-17	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	50,604	$66.51	$3,365,672	89,828
2022-04-18	Gregg Vicky B	Dir	Equity grant / award L	Common Stock	61	$134.88	$8,228	15,630
2022-04-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	306	$135.44	$41,446	11,991
2022-03-07	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	79	$130.09	$10,277	32,011
2022-03-07	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Equity grant / award A	Common Stock	206	$130.09	$26,799	32,089
2022-03-07	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	835	$130.09	$108,625	31,883
2022-03-07	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Equity grant / award A	Common Stock	2,310	$130.09	$300,508	32,718
2022-02-28	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	661	$130.00	$85,930	39,224
2022-02-24	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	109,317	$0.00	$0	109,317
2022-02-24	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Equity grant / award A	Common Stock	22,510	$0.00	$0	297,219
2022-02-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Other disposed transaction F	Common Stock	2,255	$130.23	$293,669	274,709
2022-02-23	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Other disposed transaction F	Common Stock	7,463	$130.09	$970,862	276,964
2022-01-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	247	$167.69	$41,421	11,631
2021-11-29	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	37,565	$95.80	$3,598,539	0
2021-11-29	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	14,575	$157.53	$2,296,043	68,729
2021-11-29	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	15,908	$156.85	$2,495,249	83,304
2021-11-29	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	3,532	$155.77	$550,194	99,212
2021-11-29	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	3,250	$154.79	$503,074	102,744
2021-11-29	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	300	$153.38	$46,015	105,994
2021-11-29	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Exercise / conversion M	Common Stock	37,565	$95.80	$3,598,539	106,294
2021-10-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	288	$143.76	$41,404	11,337
2021-08-16	Doi Tracey	Dir	Equity grant / award A	Common Stock	905	$0.00	$0	905
2021-07-29	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	4,193	$95.80	$401,668	0
2021-07-29	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	5,300	$95.80	$507,714	4,193
2021-07-29	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	4,193	$141.22	$592,119	284,427
2021-07-29	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	4,193	$95.80	$401,668	288,620
2021-07-29	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	5,300	$140.59	$745,132	284,427
2021-07-29	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	5,300	$95.80	$507,714	289,727
2021-07-28	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	139,751	$95.80	$13,387,447	9,493
2021-07-28	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	139,751	$140.14	$19,584,845	284,427
2021-07-28	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	139,751	$95.80	$13,387,447	424,178
2021-07-27	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	32,788	$95.80	$3,140,926	149,244
2021-07-27	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	32,788	$140.01	$4,590,550	284,427
2021-07-27	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	32,788	$95.80	$3,140,926	317,215
2021-07-27	WILENSKY GAIL R	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	6,111	$61.23	$374,146	0
2021-07-27	WILENSKY GAIL R	Dir	Open-market sell S	Common Stock	6,111	$139.27	$851,067	17,845
2021-07-27	WILENSKY GAIL R	Dir	Exercise / conversion M	Common Stock	6,111	$61.23	$374,146	23,956
2021-07-26	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	5,813	$95.80	$556,856	182,032
2021-07-26	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	5,813	$140.03	$813,994	284,427
2021-07-26	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	5,813	$95.80	$556,856	290,240
2021-07-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	313	$132.52	$41,479	11,000
2021-05-25	PFEIFFER GARY M	Dir	Equity grant / award A	Common Stock	1,363	$0.00	$0	23,265
2021-05-21	Gregg Vicky B	Dir	Equity grant / award A	Common Stock	1,363	$0.00	$0	15,400
2021-05-18	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	5	$136.60	$683	26,859
2021-05-07	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	8,536	$139.96	$1,194,724	68,729
2021-05-05	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	44,939	$71.17	$3,198,309	0
2021-05-05	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	44,939	$137.00	$6,156,643	40,152
2021-05-05	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	44,939	$71.17	$3,198,309	85,091
2021-04-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	326	$128.47	$41,853	10,639
2021-03-09	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Other disposed transaction F	Common Stock	25,887	$115.42	$2,987,878	284,427
2021-03-09	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Equity grant / award A	Common Stock	58,368	$115.42	$6,736,835	310,314
2021-02-25	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	801	$115.49	$92,507	40,152
2021-02-24	Davis J. E.	EVP, General Diagnostics	Other disposed transaction F	Common Stock	806	$121.19	$97,679	41,695
2021-02-23	Davis J. E.	EVP, General Diagnostics	Other disposed transaction F	Common Stock	1,250	$121.15	$151,438	42,501
2021-02-17	Mendez Manuel O.	SVP & Chief Commercial Officer	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	27,633	$0.00	$0	27,633
2021-02-17	Mendez Manuel O.	SVP & Chief Commercial Officer	Equity grant / award A	Common Stock	4,926	$0.00	$0	29,045
2021-01-04	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	264	$119.93	$31,662	10,313
2020-12-24	GUINAN MARK	Executive Vice President & CFO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	81,756	$66.51	$5,437,592	0
2020-12-24	GUINAN MARK	Executive Vice President & CFO	Open-market sell S	Common Stock	22,563	$121.18	$2,734,139	73,579
2020-12-24	GUINAN MARK	Executive Vice President & CFO	Open-market sell S	Common Stock	59,193	$120.06	$7,106,534	96,142
2020-12-24	GUINAN MARK	Executive Vice President & CFO	Exercise / conversion M	Common Stock	81,756	$66.51	$5,437,592	155,335
2020-11-24	WILENSKY GAIL R	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	6,111	$57.66	$352,391	0
2020-11-24	WILENSKY GAIL R	Dir	Open-market sell S	Common Stock	6,111	$126.02	$770,120	16,482
2020-11-24	WILENSKY GAIL R	Dir	Exercise / conversion M	Common Stock	6,111	$57.66	$352,391	22,593
2020-11-23	STANZIONE DANIEL	Dir	Open-market sell S	Common Stock	2,300	$127.45	$293,137	28,349
2020-11-23	STANZIONE DANIEL	Dir	Open-market sell S	Common Stock	3,302	$126.46	$417,584	30,649
2020-11-23	STANZIONE DANIEL	Dir	Open-market sell S	Common Stock	5,621	$125.73	$706,738	33,951
2020-10-21	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	5,700	$57.60	$328,348	0
2020-10-21	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	4,750	$56.82	$269,895	0
2020-10-21	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Open-market sell S	Common Stock	4,750	$125.00	$593,750	25,090
2020-10-21	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Open-market sell S	Common Stock	5,700	$125.00	$712,500	29,785
2020-10-21	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M	Common Stock	5,700	$57.60	$328,348	35,485
2020-10-21	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M	Common Stock	4,750	$56.82	$269,895	29,785
2020-10-16	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	291,997	$66.51	$19,420,720	0
2020-10-16	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	291,997	$120.00	$35,039,640	237,747
2020-10-16	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	291,997	$66.51	$19,420,720	529,744
2020-10-14	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	35,591	$52.16	$1,856,605	0
2020-10-14	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	35,591	$119.00	$4,235,329	40,087
2020-10-14	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	35,591	$52.16	$1,856,605	75,678
2020-10-06	Mendez Manuel O.	SVP & Chief Commercial Officer	Other disposed transaction F	Common Stock	5,871	$114.01	$669,353	23,982
2020-10-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	270	$114.01	$30,783	10,005
2020-09-02	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	58,392	$66.51	$3,883,652	0
2020-09-02	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	3,776	$111.13	$419,616	68,411
2020-09-02	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	54,616	$110.57	$6,038,727	72,187
2020-09-02	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Exercise / conversion M	Common Stock	58,392	$66.51	$3,883,652	126,803
2020-07-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	203	$113.73	$23,087	9,693
2020-06-08	GUINAN MARK	Executive Vice President & CFO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	72,596	$71.17	$5,166,657	0
2020-06-08	GUINAN MARK	Executive Vice President & CFO	Open-market sell S	Common Stock	8,524	$118.60	$1,010,980	73,579
2020-06-08	GUINAN MARK	Executive Vice President & CFO	Open-market sell S	Common Stock	18,246	$117.65	$2,146,624	82,103
2020-06-08	GUINAN MARK	Executive Vice President & CFO	Open-market sell S	Common Stock	45,826	$116.81	$5,352,981	100,349
2020-06-08	GUINAN MARK	Executive Vice President & CFO	Exercise / conversion M	Common Stock	72,596	$71.17	$5,166,657	146,175
2020-05-19	Lassiter Wright III	Dir	Equity grant / award A	Common Stock	1,531	$0.00	$0	1,882
2020-05-18	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	5	$107.42	$537	25,035
2020-04-27	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	11,717	$71.17	$833,899	0
2020-04-27	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	11,717	$112.01	$1,312,433	237,747
2020-04-27	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	11,717	$71.17	$833,899	249,464
2020-04-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	403	$76.55	$30,850	9,434
2020-03-16	Davis J. E.	EVP, General Diagnostics	Open-market sell S	Common Stock	500	$90.15	$45,073	38,086
2020-03-16	Davis J. E.	EVP, General Diagnostics	Open-market sell S	Common Stock	421	$88.53	$37,269	38,586
2020-03-16	Davis J. E.	EVP, General Diagnostics	Open-market sell S	Common Stock	1,307	$87.81	$114,772	39,007
2020-03-16	Davis J. E.	EVP, General Diagnostics	Open-market sell S	Common Stock	1,085	$86.65	$94,020	40,314
2020-03-16	Davis J. E.	EVP, General Diagnostics	Open-market sell S	Common Stock	200	$85.59	$17,118	41,399
2020-03-12	Lassiter Wright III	Dir	Equity grant / award A	Common Stock	351	$0.00	$0	351
2020-03-10	Davis J. E.	EVP, General Diagnostics	Other disposed transaction F	Common Stock	3,846	$106.46	$409,445	41,599
2020-03-10	Davis J. E.	EVP, General Diagnostics	Equity grant / award A	Common Stock	7,359	$106.46	$783,439	45,445
2020-03-06	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	230,178	$71.17	$16,381,768	11,817
2020-03-06	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	2,000	$116.27	$232,544	226,560
2020-03-06	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	3,937	$115.45	$454,535	228,560
2020-03-06	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	16,426	$114.24	$1,876,441	232,497
2020-03-06	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	36,790	$113.65	$4,181,257	248,923
2020-03-06	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Open-market sell S	Common Stock	171,025	$112.21	$19,190,202	285,713
2020-03-06	RUSCKOWSKI STEPHEN H	Chairman, CEO and President	Exercise / conversion M	Common Stock	230,178	$71.17	$16,381,768	456,738
2020-02-27	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	690	$109.02	$75,224	40,087
2020-02-26	PREVOZNIK MICHAEL E	SVP & General Counsel	Other disposed transaction F	Common Stock	668	$112.90	$75,417	40,777
2020-02-26	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	321	$111.09	$35,660	41,445
2020-02-25	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	49	$113.34	$5,554	24,514
2020-02-24	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Other disposed transaction F	Common Stock	56	$112.17	$6,282	24,563
2020-02-18	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	5,059	$0.00	$0	5,059
2020-02-18	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Equity grant / award A	Common Stock	776	$0.00	$0	24,619
2020-02-07	PREVOZNIK MICHAEL E	SVP & General Counsel	Equity grant / award G	Common Stock	480	$0.00	$0	38,978
2020-01-02	EGLINTON MANNER CARRIE	SVP, Advanced Diagnostics	Other disposed transaction F	Common Stock	1,543	$106.52	$164,360	21,250
2019-11-27	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	32,693	$56.12	$1,834,731	0
2019-11-27	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	11,863	$52.16	$618,833	35,591
2019-11-27	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	500	$107.83	$53,915	39,458
2019-11-27	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	32,193	$107.53	$3,461,552	39,958
2019-11-27	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	11,863	$107.15	$1,271,097	72,151
2019-11-27	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	32,693	$56.12	$1,834,731	84,014
2019-11-27	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	11,863	$52.16	$618,833	51,321
2019-11-26	WILENSKY GAIL R	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	8,000	$55.76	$446,080	0
2019-11-26	WILENSKY GAIL R	Dir	Open-market sell S	Common Stock	8,000	$107.17	$857,352	14,951
2019-11-26	WILENSKY GAIL R	Dir	Exercise / conversion M	Common Stock	8,000	$55.76	$446,080	22,951
2019-10-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	288	$0.00	$0	8,654
2019-09-17	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	5,000	$55.65	$278,250	0
2019-09-17	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Open-market sell S	Common Stock	5,000	$106.00	$530,000	23,732
2019-09-17	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Exercise / conversion M	Common Stock	5,000	$55.65	$278,250	28,671
2019-07-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	300	$102.77	$30,830	8,321
2019-06-13	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Exercise / conversion M · derivative	Stock Options (Right to Buy)	244,565	$52.16	$12,757,733	0
2019-06-13	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Open-market sell S	Common Stock	244,565	$100.00	$24,456,500	213,049
2019-06-13	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Exercise / conversion M	Common Stock	244,565	$52.16	$12,757,733	457,614
2019-05-14	PFEIFFER GARY M	Dir	Equity grant / award A	Common Stock	1,722	$0.00	$0	19,563
2019-05-13	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	608	$0.00	$0	608
2019-05-13	DEPPE MICHAEL J	VP, Corp. Controller & CAO	Equity grant / award A	Common Stock	52	$0.00	$0	23,671
2019-04-24	Davis J. E.	EVP, General Diagnostics	Exercise / conversion M · derivative	Stock Options (Right to Buy)	47,574	$60.67	$2,886,552	0
2019-04-24	Davis J. E.	EVP, General Diagnostics	Open-market sell S	Common Stock	47,574	$95.00	$4,519,530	36,534
2019-04-24	Davis J. E.	EVP, General Diagnostics	Exercise / conversion M	Common Stock	47,574	$60.67	$2,886,552	84,108
2019-04-08	Davis J. E.	EVP, General Diagnostics	Open-market sell S	Common Stock	2,100	$90.70	$190,476	36,534
2019-04-08	Davis J. E.	EVP, General Diagnostics	Open-market sell S	Common Stock	5,900	$90.14	$531,856	38,634
2019-04-04	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	60,492	$71.17	$4,305,216	0
2019-04-04	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	5,890	$90.59	$533,587	67,526
2019-04-04	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	60,492	$90.59	$5,480,152	73,416
2019-04-04	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Exercise / conversion M	Common Stock	60,492	$71.17	$4,305,216	133,908
2019-04-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	340	$90.60	$30,804	7,972
2019-03-01	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Other disposed transaction F	Common Stock	22,698	$86.86	$1,971,548	213,049
2019-03-01	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Equity grant / award A	Common Stock	38,341	$86.86	$3,330,299	235,747
2019-02-26	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Other disposed transaction F	Common Stock	6,676	$87.84	$586,420	197,406
2019-02-25	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Other disposed transaction F	Common Stock	2,318	$88.24	$204,540	204,082
2019-02-22	WILENSKY GAIL R	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	8,000	$51.55	$412,400	0
2019-02-22	WILENSKY GAIL R	Dir	Open-market sell S	Common Stock	8,000	$87.78	$702,216	26,604
2019-02-22	WILENSKY GAIL R	Dir	Exercise / conversion M	Common Stock	8,000	$51.55	$412,400	34,604
2019-02-18	MORRISON DENISE M	Dir	Equity grant / award A · derivative	Phantom Stock Units	163	$86.63	$14,121	163
2019-02-18	MORRISON DENISE M	Dir	Equity grant / award A	Common Stock	484	$0.00	$0	484
2019-01-02	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	376	$82.00	$30,830	7,585
2018-12-31	EGLINTON MANNER CARRIE	SVP, Advanced Diagnostics	Other disposed transaction F	Common Stock	1,767	$82.27	$145,371	19,507
2018-10-12	Klug Robert A	VP, Corporate Controller	Other disposed transaction F	Common Stock	8	$100.51	$804	4,972
2018-10-01	Torley Helen	Dir	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	1,298	$0.00	$0	1,298
2018-08-17	Klug Robert A	VP, Corporate Controller	Other disposed transaction F	Common Stock	21	$0.00	$0	4,928
2018-07-10	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	30,780	$57.60	$1,773,082	0
2018-07-10	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	30,780	$113.06	$3,480,141	39,791
2018-07-10	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	30,780	$57.60	$1,773,082	70,551
2018-07-02	Cunningham Everett	SVP, Commercial	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	38,928	$66.51	$2,589,101	19,464
2018-07-02	Cunningham Everett	SVP, Commercial	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	21,294	$52.16	$1,110,802	0
2018-07-02	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	781	$110.12	$86,007	38,261
2018-07-02	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	7,066	$109.63	$774,624	38,850
2018-07-02	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	5,583	$110.07	$614,498	45,916
2018-07-02	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	33,345	$109.60	$3,654,479	51,499
2018-07-02	Cunningham Everett	SVP, Commercial	Exercise / conversion M	Common Stock	38,928	$66.51	$2,589,101	84,844
2018-07-02	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	1,496	$110.12	$164,743	45,916
2018-07-02	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	19,798	$109.64	$2,170,692	47,412
2018-07-02	Cunningham Everett	SVP, Commercial	Exercise / conversion M	Common Stock	21,294	$52.16	$1,110,802	67,210
2018-06-04	BRITELL JENNE K	Dir	Equity grant / award G	Common Stock	8,704	$0.00	$0	14,479
2018-06-01	Torley Helen	Dir	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	665	$0.00	$0	665
2018-05-29	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	1,644	$105.61	$173,623	6,000
2018-05-25	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Exercise / conversion M · derivative	Stock Options (Right to Buy)	168,490	$56.12	$9,455,659	0
2018-05-25	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Open-market sell S	Common Stock	168,490	$107.00	$18,028,430	191,069
2018-05-25	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Exercise / conversion M	Common Stock	168,490	$56.12	$9,455,659	359,559
2018-05-15	Torley Helen	Dir	Equity grant / award A	Common Stock	1,644	$0.00	$0	1,644
2018-04-02	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	313	$98.54	$30,843	6,546
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	38,928	$66.51	$2,589,101	19,464
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	7,773	$104.77	$814,377	31,757
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	2,800	$104.77	$293,356	39,530
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	34,168	$104.09	$3,556,479	42,330
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	1,300	$104.77	$136,197	76,498
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	18,164	$104.09	$1,890,654	77,798
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	1,427	$104.76	$149,493	95,962
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	18,037	$104.08	$1,877,381	97,389
2018-03-08	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Exercise / conversion M	Common Stock	38,928	$66.51	$2,589,101	115,426
2018-03-02	GUINAN MARK	Executive Vice President & CFO	Other disposed transaction F	Common Stock	6,471	$101.00	$653,571	58,200
2018-03-02	GUINAN MARK	Executive Vice President & CFO	Equity grant / award A	Common Stock	13,137	$101.00	$1,326,837	64,671
2018-03-01	Cunningham Everett	SVP, Commercial	Equity grant / award G	Common Stock	491	$104.78	$51,445	37,760
2018-02-27	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Other disposed transaction F	Common Stock	3,017	$101.43	$306,014	170,708
2018-02-27	GUINAN MARK	Executive Vice President & CFO	Other disposed transaction F	Common Stock	779	$101.43	$79,014	51,534
2018-02-26	PREVOZNIK MICHAEL E	SVP & General Counsel	Other disposed transaction F	Common Stock	900	$101.43	$91,287	41,671
2018-02-26	GUINAN MARK	Executive Vice President & CFO	Other disposed transaction F	Common Stock	1,454	$101.43	$147,479	52,313
2018-02-23	PREVOZNIK MICHAEL E	SVP & General Counsel	Other disposed transaction F	Common Stock	317	$102.69	$32,553	42,571
2018-02-23	GUINAN MARK	Executive Vice President & CFO	Other disposed transaction F	Common Stock	592	$102.69	$60,792	53,767
2018-02-19	GUINAN MARK	Executive Vice President & CFO	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	50,764	$0.00	$0	50,764
2018-02-19	GUINAN MARK	Executive Vice President & CFO	Equity grant / award A	Common Stock	4,442	$0.00	$0	54,359
2018-01-29	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Exercise / conversion M · derivative	Stock Options (Right to Buy)	106,840	$58.17	$6,215,417	0
2018-01-29	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Open-market sell S	Common Stock	106,840	$107.00	$11,431,880	166,116
2018-01-29	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Exercise / conversion M	Common Stock	106,840	$58.17	$6,215,417	272,956
2018-01-24	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Exercise / conversion M · derivative	Stock Options (Right to Buy)	21,294	$52.16	$1,110,802	0
2018-01-24	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	21,294	$104.00	$2,214,576	69,415
2018-01-24	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Exercise / conversion M	Common Stock	21,294	$52.16	$1,110,802	90,709
2018-01-02	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	312	$98.72	$30,802	6,206
2017-10-13	Klug Robert A	VP, Corporate Controller	Other disposed transaction F	Common Stock	9	$91.10	$820	4,515
2017-10-02	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	330	$93.52	$30,862	5,867
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	5,221	$61.23	$319,656	0
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	4,268	$57.56	$245,687	0
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	5,592	$61.23	$342,370	0
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	5,592	$57.66	$322,463	0
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	7,319	$55.76	$408,107	0
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	7,316	$51.55	$377,140	0
2017-09-11	STANZIONE DANIEL	Dir	Open-market sell S	Common Stock	40,900	$108.07	$4,419,940	34,675
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	5,221	$61.23	$319,656	64,391
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	4,268	$57.56	$245,687	59,170
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	5,592	$61.23	$342,370	75,575
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	7,319	$55.76	$408,107	49,310
2017-09-11	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	7,316	$51.55	$377,140	41,991
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	1,004	$61.23	$61,470	5,221
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	915	$57.56	$52,672	4,268
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	519	$57.66	$29,928	5,592
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	681	$55.76	$37,973	7,319
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	684	$51.55	$35,260	7,316
2017-09-05	STANZIONE DANIEL	Dir	Open-market sell S	Common Stock	3,803	$108.01	$410,762	34,675
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	1,004	$61.23	$61,470	38,478
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	915	$57.56	$52,672	37,474
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	519	$57.67	$29,931	36,559
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	681	$55.76	$37,973	36,040
2017-09-05	STANZIONE DANIEL	Dir	Exercise / conversion M	Common Stock	684	$51.55	$35,260	35,359
2017-08-04	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	296	$106.66	$31,571	6,000
2017-08-01	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Equity grant / award G	Common Stock	2,500	$0.00	$0	70,683
2017-07-27	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	1,304	$108.73	$141,783	6,296
2017-07-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	276	$111.81	$30,860	5,516
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Exercise / conversion M · derivative	Stock Options (Right to Buy)	63,880	$52.16	$3,332,300	0
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Exercise / conversion M · derivative	Stock Options (Right to Buy)	29,340	$56.12	$1,646,561	0
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Exercise / conversion M · derivative	Stock Options (Right to Buy)	13,680	$57.60	$788,036	0
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	2,559	$108.13	$276,715	73,183
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	61,321	$107.53	$6,593,786	75,742
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	1,158	$108.14	$125,223	137,063
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	28,182	$107.53	$3,030,326	138,221
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	336	$108.15	$36,338	166,403
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Open-market sell S	Common Stock	13,344	$107.52	$1,434,747	166,739
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Exercise / conversion M	Common Stock	63,880	$52.16	$3,332,300	180,083
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Exercise / conversion M	Common Stock	29,340	$56.12	$1,646,561	116,203
2017-06-19	Cohen Jon R	SVP & Group Exec. Diag. Sol.	Exercise / conversion M	Common Stock	13,680	$57.60	$788,036	86,863
2017-05-19	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Equity grant / award G	Common Stock	4,740	$0.00	$0	69,415
2017-05-16	STANZIONE DANIEL	Dir	Equity grant / award A	Common Stock	1,573	$0.00	$0	34,675
2017-04-24	BRITELL JENNE K	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	6,111	$57.67	$352,421	0
2017-04-24	BRITELL JENNE K	Dir	Open-market sell S	Common Stock	6,111	$104.03	$635,727	19,903
2017-04-24	BRITELL JENNE K	Dir	Exercise / conversion M	Common Stock	6,111	$57.67	$352,421	25,996
2017-04-20	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	28,500	$56.82	$1,619,370	0
2017-04-20	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	1,013	$55.65	$56,373	0
2017-04-20	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	28,500	$100.00	$2,850,000	40,327
2017-04-20	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	28,500	$56.82	$1,619,370	68,822
2017-04-20	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	1,013	$100.00	$101,300	40,322
2017-04-20	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	1,013	$55.65	$56,373	41,335
2017-04-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	315	$97.62	$30,750	5,216
2017-03-16	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	13,987	$55.65	$778,377	1,013
2017-03-16	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	13,987	$100.00	$1,398,700	40,322
2017-03-16	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	13,987	$55.65	$778,377	54,309
2017-03-03	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	6,028	$98.29	$592,492	74,155
2017-03-03	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	4,478	$98.29	$440,143	40,322
2017-03-02	PREVOZNIK MICHAEL E	SVP & General Counsel	Other disposed transaction F	Common Stock	4,824	$98.12	$473,331	44,800
2017-03-02	PREVOZNIK MICHAEL E	SVP & General Counsel	Equity grant / award A	Common Stock	9,302	$98.12	$912,712	49,619
2017-03-02	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Open-market sell S	Common Stock	1,134	$98.25	$111,416	80,183
2017-03-02	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Other disposed transaction F	Common Stock	6,492	$98.12	$636,995	81,317
2017-03-02	Doherty Catherine T.	SVP, Group Exec. Clin. Fran.	Equity grant / award A	Common Stock	12,520	$98.12	$1,228,462	87,809
2017-03-01	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	470	$97.77	$45,952	40,317
2017-02-28	Klug Robert A	VP, Corporate Controller	Other disposed transaction F	Common Stock	69	$96.42	$6,653	3,505
2017-02-24	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Other disposed transaction F	Common Stock	2,759	$95.68	$263,981	147,911
2017-02-22	ZIEGLER JOHN B	Dir	Open-market sell S	Common Stock	2,000	$95.51	$191,016	16,557
2017-02-21	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Equity grant / award A · derivative	Non-Qualifed Stock Option (right to buy)	187,845	$0.00	$0	187,845
2017-02-21	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Equity grant / award A	Common Stock	15,659	$0.00	$0	150,670
2017-02-15	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Open-market sell S	Common Stock	1,615	$94.65	$152,858	73,380
2017-02-13	RUSCKOWSKI STEPHEN H	Chairman, President and CEO	Other disposed transaction F	Common Stock	5,686	$93.85	$533,631	135,011
2017-02-02	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	15,000	$55.65	$834,750	15,000
2017-02-02	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M · derivative	Stock Options (Right to Buy)	30,000	$51.20	$1,536,000	0
2017-02-02	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	15,000	$92.38	$1,385,745	41,986
2017-02-02	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	15,000	$55.65	$834,750	56,918
2017-02-02	PREVOZNIK MICHAEL E	SVP & General Counsel	Open-market sell S	Common Stock	30,000	$92.39	$2,771,850	41,918
2017-02-02	PREVOZNIK MICHAEL E	SVP & General Counsel	Exercise / conversion M	Common Stock	30,000	$51.20	$1,536,000	71,918
2017-01-30	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Exercise / conversion M · derivative	Stock Options (Right to Buy)	37,414	$56.12	$2,099,674	6,595
2017-01-30	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Exercise / conversion M · derivative	Stock Options (Right to Buy)	42,586	$52.16	$2,221,499	21,294
2017-01-30	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Open-market sell S	Common Stock	37,414	$90.40	$3,382,076	76,735
2017-01-30	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Exercise / conversion M	Common Stock	37,414	$56.12	$2,099,674	114,149
2017-01-30	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Open-market sell S	Common Stock	11,486	$91.61	$1,052,255	76,735
2017-01-30	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Open-market sell S	Common Stock	31,100	$90.42	$2,812,031	88,221
2017-01-30	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Exercise / conversion M	Common Stock	42,586	$52.16	$2,221,499	119,321
2017-01-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	333	$93.07	$30,992	4,878
2016-11-15	PFEIFFER GARY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	6,111	$0.00	$0	0
2016-11-15	PFEIFFER GARY M	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	8,000	$0.00	$0	0
2016-11-15	PFEIFFER GARY M	Dir	Open-market sell S	Common Stock	8,310	$85.25	$708,461	13,698
2016-11-15	PFEIFFER GARY M	Dir	Open-market sell S	Common Stock	6,111	$85.18	$520,559	22,008
2016-11-15	PFEIFFER GARY M	Dir	Exercise / conversion M	Common Stock	6,111	$61.23	$374,146	28,119
2016-11-15	PFEIFFER GARY M	Dir	Open-market sell S	Common Stock	8,000	$84.94	$679,504	22,008
2016-11-15	PFEIFFER GARY M	Dir	Exercise / conversion M	Common Stock	8,000	$55.76	$446,080	30,008
2016-10-13	Klug Robert A	VP, Corporate Controller	Equity grant / award A	Common Stock	91	$0.00	$0	3,043
2016-10-03	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	367	$83.69	$30,714	4,523
2016-08-22	Klug Robert A	VP, Corporate Controller	Other disposed transaction F	Common Stock	84	$84.57	$7,104	2,888
2016-08-19	BRITELL JENNE K	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	4,000	$55.76	$223,040	0
2016-08-19	BRITELL JENNE K	Dir	Open-market sell S	Common Stock	4,000	$84.76	$339,052	19,885
2016-08-19	BRITELL JENNE K	Dir	Exercise / conversion M	Common Stock	4,000	$55.76	$223,040	23,885
2016-08-18	Klug Robert A	VP, Corporate Controller	Other disposed transaction F	Common Stock	11	$84.89	$934	2,972
2016-08-10	BRITELL JENNE K	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	4,000	$55.76	$223,040	4,000
2016-08-10	BRITELL JENNE K	Dir	Open-market sell S	Common Stock	4,000	$85.20	$340,808	19,885
2016-08-10	BRITELL JENNE K	Dir	Exercise / conversion M	Common Stock	4,000	$55.76	$223,040	23,876
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	311	$70.37	$21,885	0
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	1,747	$61.37	$107,213	0
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	1,563	$72.92	$113,974	0
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	1,518	$76.06	$115,467	0
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	1,502	$68.68	$103,157	0
2016-08-03	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	311	$85.61	$26,625	6,027
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M	Common Stock	311	$70.37	$21,885	6,338
2016-08-03	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	1,747	$85.57	$149,486	6,027
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M	Common Stock	1,747	$61.37	$107,213	7,774
2016-08-03	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	1,563	$85.65	$133,866	6,027
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M	Common Stock	1,563	$72.92	$113,974	7,590
2016-08-03	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	800	$85.66	$68,526	6,027
2016-08-03	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	718	$85.65	$61,497	6,827
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M	Common Stock	1,518	$76.06	$115,467	7,545
2016-08-03	LEIDEN JEFFREY M	Dir	Open-market sell S	Common Stock	1,206	$85.62	$103,263	6,027
2016-08-03	LEIDEN JEFFREY M	Dir	Exercise / conversion M	Common Stock	1,502	$68.68	$103,157	7,233
2016-07-25	ZIEGLER JOHN B	Dir	Open-market sell S	Common Stock	1,000	$84.36	$84,359	18,557
2016-07-01	RING TIMOTHY M	Dir	Equity grant / award A · derivative	Phantom Stock Units	381	$80.99	$30,857	4,136
2016-05-27	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Exercise / conversion M · derivative	Stock Options (Right to Buy)	23,667	$56.82	$1,344,759	0
2016-05-27	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Open-market sell S	Common Stock	23,667	$77.26	$1,828,607	76,735
2016-05-27	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Exercise / conversion M	Common Stock	23,667	$56.82	$1,344,759	124,069
2016-05-23	Davis J. E.	SVP, Regional Businesses	Other disposed transaction F	Common Stock	1,907	$76.30	$145,504	30,077
2016-05-17	ZIEGLER JOHN B	Dir	Equity grant / award A	Common Stock	2,196	$0.00	$0	19,539
2016-05-12	BRITELL JENNE K	Dir	Exercise / conversion M · derivative	Stock Options (Right to Buy)	8,000	$51.55	$412,400	0
2016-05-12	BRITELL JENNE K	Dir	Open-market sell S	Common Stock	8,000	$75.68	$605,456	11,655
2016-05-12	BRITELL JENNE K	Dir	Exercise / conversion M	Common Stock	8,000	$51.55	$412,400	19,655
2016-05-09	Cunningham Everett	SVP, Commercial	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	13,252	$71.17	$943,145	40,328
2016-05-09	Cunningham Everett	SVP, Commercial	Exercise / conversion M · derivative	Stock Options (Right to Buy)	43,060	$56.12	$2,416,527	0
2016-05-09	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	13,252	$76.21	$1,009,908	31,889
2016-05-09	Cunningham Everett	SVP, Commercial	Exercise / conversion M	Common Stock	13,252	$71.17	$943,145	45,141
2016-05-09	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	43,060	$76.28	$3,284,488	31,889
2016-05-09	Cunningham Everett	SVP, Commercial	Exercise / conversion M	Common Stock	43,060	$56.12	$2,416,527	74,949
2016-05-06	Cunningham Everett	SVP, Commercial	Exercise / conversion M · derivative	Non-Qualifed Stock Option (right to buy)	6,912	$71.17	$491,927	53,580
2016-05-06	Cunningham Everett	SVP, Commercial	Exercise / conversion M · derivative	Stock Options (Right to Buy)	42,586	$52.16	$2,221,499	21,294
2016-05-06	Cunningham Everett	SVP, Commercial	Exercise / conversion M · derivative	Stock Options (Right to Buy)	949	$56.12	$53,258	43,060
2016-05-06	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	6,912	$76.00	$525,312	31,889
2016-05-06	Cunningham Everett	SVP, Commercial	Exercise / conversion M	Common Stock	6,912	$71.17	$491,927	38,612
2016-05-06	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	42,586	$76.00	$3,236,536	31,700
2016-05-06	Cunningham Everett	SVP, Commercial	Exercise / conversion M	Common Stock	42,586	$52.16	$2,221,499	74,286
2016-05-06	Cunningham Everett	SVP, Commercial	Open-market sell S	Common Stock	949	$76.00	$72,124	31,700
2016-05-06	Cunningham Everett	SVP, Commercial	Exercise / conversion M	Common Stock	949	$56.12	$53,258	32,649
2016-04-25	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Exercise / conversion M · derivative	Stock Options (Right to Buy)	23,667	$51.20	$1,211,750	0
2016-04-25	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Open-market sell S	Common Stock	5,883	$74.40	$437,695	76,735
2016-04-25	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Open-market sell S	Common Stock	23,667	$74.46	$1,762,221	82,618
2016-04-25	Doherty Catherine T.	SVP, Clin. Franchise Solutions	Exercise / conversion M	Common Stock	23,667	$51.20	$1,211,750	106,285

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count